Exciting news from Lipocine Inc.! The company has just unveiled a groundbreaking license and supply agreement for its innovative testosterone replacement therapy, TLANDO®, in Brazil. This strategic partnership is set to broaden access to this vital treatment across the Brazilian market, significantly boosting Lipocine’s presence on the global stage.